Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-cultures
Cancer Immunology, Immunotherapy · 02.07.2024 · 73 (9)
DOI: 10.1007/s00262-024-03749-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 02.07.2024. Verfasst von Zhilang Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China. Hauptthemen laut MEDLINE: Lymphocytes, Tumor-Infiltrating, Receptors, Antigen, T-Cell, Coculture Techniques, Organoids. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Natural Science Foundation of China.
Abstract (Originalsprache)
T cell receptor-engineered T cells (TCR-Ts) therapy is promising for cancer immunotherapy. Most studies have focused on identifying tumor-specific T cell receptors (TCRs) through predicted tumor neoantigens. However, current algorithms for predicting tumor neoantigens are unreliable and many neoantigens are derived from non-coding regions. Thus, the technological platform for identifying tumor-specific TCRs using natural antigens expressed on tumor cells is urgently needed. In this study, tumor organoids-enriched tumor infiltrating lymphocytes (oeT) were obtained by repeatedly stimulation of autologous patient-derived organoids (PDO) in vitro. The oeT cells specifically responded to autologous tumor PDO by detecting CD137 expression and the secretion of IFN-γ using enzyme-linked immunospot assay. The measurement of oeT cell-mediated killing of three-dimensional organoids was conducted using a caspase3/7 flow cytometry assay kit. Subsequently, tumor-specific T cells were isolated based on CD137 expression and their TCRs were identified through single-cell RT-PCR analysis. The specificity cytotoxicity of TCRs were confirmed by transferring to primary peripheral blood T cells. The co-culture system proved highly effective in generating CD8 + tumor-specific oeT cells. These oeT cells effectively induced IFN-γ secretion and exhibited specificity in killing autologous tumor organoids, while not eliciting a cytotoxic response against normal organoids. The analysis conducted by TCRs revealed a significant expansion of T cells within a specific subset of TCRs. Subsequently, the TCRs were cloned and transferred to peripheral blood T cells generation engineered TCR-Ts, which adequately recognized and killed tumor cell in a patient-specific manner. The co-culture system provided an approach to generate tumor-specific TCRs from tumor-infiltrating lymphocytes of patients with colorectal cancer, and tumor-specific TCRs can potentially be used for personalized TCR-T therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China.
- Department of Gastrointestinal Surgery, Peking University Shougang Hospital, Beijing, 100041, China.
- Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, 100091, China.
- Department of Cell Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China. baiyun@bjmu.edu.cn.
- Department of Cell Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China. hongkui_deng@pku.edu.cn.
Förderung
- The National Natural Science Foundation of China
Zitieren
APA
Li, Z., Ma, L., Gao, Z., Wang, X., Che, X., Zhang, P., Li, Y., Zhang, Q., Liu, T., Sun, Y., Bai, Y., & Deng, H. (2024). Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-cultures. Cancer Immunology, Immunotherapy, 73(9). https://doi.org/10.1007/s00262-024-03749-8
Vancouver
Li Z, Ma L, Gao Z, Wang X, Che X, Zhang P, et al. Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-cultures. Cancer Immunology, Immunotherapy. 2024;73(9). doi:10.1007/s00262-024-03749-8
BibTeX
@article{Li2024,
author = {Li, Zhilang and Ma, Lisha and Gao, Zhaoya and Wang, Xiya and Che, Xuan and Zhang, Pengchong and Li, Yixian and Zhang, Qianjing and Liu, Tianxing and Sun, Yuan and Bai, Yun and Deng, Hongkui},
title = {Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-cultures},
journal = {Cancer Immunology, Immunotherapy},
year = {2024},
volume = {73},
number = {9},
doi = {10.1007/s00262-024-03749-8}
}
EUVIMED